首页> 中文期刊> 《上海医药》 >2009-2011年上海医院抗肿瘤用药分析

2009-2011年上海医院抗肿瘤用药分析

         

摘要

Objective:To investigate the clinical application of anticancer drugs in Shanghai sample hospitals during 2009-2011 so as to provide a refrence for the production, marketing and application and so on. Methods:The data on anticancer drugs used in 119 Shanghai sample hospitals were compared and analyzed in respect to the clinical applications. Results:The demand for anticancer drugs had been rapidly growing. The main varieties are docetaxel, oxaliplatin, paclitaxel, gemcitabine, pemetrexed and capecitabine, etc. Traditional Chinese medicine preparations are Adie, Fufang Banmao, etc. The novel targeted drugs are trastuzumab, rituximab, etc. Conclusion: It is the most urgent task to develop the effective, safe and inexpensive anticancer drugs.%  目的:了解2009-2011年上海医院抗肿瘤药物临床应用,供生产、营销和使用等部门参考。方法:根据上海119家样本医院提供的2009-2011年抗肿瘤用药数据,3年比较,结合临床应用进行分析讨论。结果:近年来抗肿瘤药物需求量迅速增长,常用品种有多西他赛、奥沙利铂、紫杉醇、吉西他滨、培美曲塞和卡培他滨等,中药制剂有“爱迪”、复方斑蝥等,新型靶向药物有曲妥珠单抗、利妥昔单抗等。结论:开发高效、低毒、价廉的抗肿瘤药物是当今迫切的任务。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号